Belite Bio (BLTE) Tops Q3 EPS by 22c

Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.22 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• What Delta’s report tells investors in American and United
• Discovery Energy Metals plans private placement of up to $1.25M